StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.29−0.26 (-10.20%)

Close on Nov 20, 2026Market cap $20.65MP/E –Yield –

Nasus Pharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Nasus Pharma

Nasus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nasus Pharma figures

See a number that looks wrong?